Tag Archives: adherence
By Clark Herman | Published: August 1, 2013
On Friday, the New England Health Institute (NEHI), outlined six “Priorities for Action” to help steer the solution to better medication adherence in the US. These priorities signal public and private policymakers alike to improve the way patients take their medication.
By Clark Herman | Published: July 12, 2013
Prescription abandonment—cited as one of the major cost-related issues in healthcare—has prompted numerous efforts to raise the profile of pharmacists in driving improvements in patient utilization. With a marked decline in engagement elsewhere—physician prescribers are seeing fewer sales reps and DTC spending is ebbing – more solutions providers are seeking to fill the gap, with […]
By Clark Herman | Published: May 30, 2013
PharmExec sat down with Colleen A. McHorney, PhD, former Senior Scientist at Merck’s U.S. Outcomes Research to review her long record of scientific research on adherence in advance of her retirement last month. McHorney highlights the cyclical nature of engagement on adherence programs, technology’s inherent inadequacies, the need to study the provider as well as […]
By Guest Blogger | Published: April 8, 2013
by Grant Corbett Improving brand adherence rates requires pharma marketers to have access to two growing bodies of knowledge. These are: 1) carefully evaluated evidence for what can improve brand revenue, and 2) informed forecasts of trends.
By Guest Blogger | Published: March 12, 2013
by Grant Corbett Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. Human genes are formed from DNA, which are instructions much like a blueprint. Similarly, the environment is changing pharmaceutical DNA and how brand marketing is instructed.